Pro Re Nata brolucizumab for early onset and treatment-naïve diabetic macular edema: A prospective study.
Alper BilgicLaurent KodjikianAditya SudhalkarJesus Hernan Gonzalez-CortesFrancesc March de RibotRiddhima DeshpandeMartin S SpitzerThibaud MathisPublished in: European journal of ophthalmology (2024)
Brolucizumab therapy for DME is a safe and effective modality for the treatment of recent DME and has the potential to reduce the number of injections.